TRINITY BIOTECH INVT LTD's ticker is and the CUSIP is 89643QAB4. A total of 3 filers reported holding TRINITY BIOTECH INVT LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 5.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $33,947,000 | +13.6% | 39,515,000 | 0.0% | 7.46% | -47.5% |
| Q3 2021 | $29,883,000 | -5.5% | 39,515,000 | 0.0% | 14.20% | -7.6% |
| Q2 2021 | $31,612,000 | 0.0% | 39,515,000 | 0.0% | 15.37% | +3.5% |
| Q1 2021 | $31,612,000 | +6.7% | 39,515,000 | 0.0% | 14.85% | +65.5% |
| Q4 2020 | $29,636,000 | +9.9% | 39,515,000 | 0.0% | 8.98% | -38.3% |
| Q3 2020 | $26,969,000 | +18.5% | 39,515,000 | +21.6% | 14.55% | +144.6% |
| Q2 2020 | $22,766,000 | +3.2% | 32,500,000 | 0.0% | 5.95% | -18.5% |
| Q1 2020 | $22,055,000 | -6.4% | 32,500,000 | 0.0% | 7.30% | -9.0% |
| Q4 2019 | $23,563,000 | +39.4% | 32,500,000 | +25.0% | 8.02% | +74.4% |
| Q3 2019 | $16,900,000 | -13.3% | 26,000,000 | 0.0% | 4.60% | -17.8% |
| Q2 2019 | $19,500,000 | -2.6% | 26,000,000 | 0.0% | 5.59% | -7.3% |
| Q1 2019 | $20,020,000 | +2.7% | 26,000,000 | 0.0% | 6.03% | -33.7% |
| Q4 2018 | $19,500,000 | -3.8% | 26,000,000 | 0.0% | 9.09% | +18.3% |
| Q3 2018 | $20,280,000 | – | 26,000,000 | – | 7.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |